Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Endocrinology | Hematology | Musculoskeletal
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Procter & Gamble, Hoechst Marion Roussel
Approval Status: Approved April 1998
Treatment Area: Paget's Disease
Actonel has been approved as a new therapy for treating
Paget's disease of the bone.
Approval is based on an 18-month, double-blind,
active-controlled pivotal trial of 123 patients with
moderate-to-severe Paget's disease, which showed disease
remission in the majority of patients who received Actonel.
